Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-23

FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) by NorthStar Rx LLC under ANDA078776. This confirms approval of a generic on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)